VERV 241220 7.50C (VERV241220C7500) Stock Options, News & Quotes - Moomoo

English
中文繁體
中文简体

Mobile

donwloadimg

Moomoo Desktop

The next-gen workspace

Click to view more download content

Sign up/Log in

English
中文繁體
中文简体

Dark
Light

Open Account

US OptionsDetailed Quotes

VERV241220C7500

Watchlist

0.39
-0.31-44.29%

15min DelayClose Dec 3 13:59 ET

0.70High0.39Low

Intraday

5D
Daily

News

Express News | Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersNov 29 16:05 ET
Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Verve TherapeuticsNov 29 00:00 ET
Express News | Bvf Partners LP Reports 8.2% Passive Stake in Verve Therapeutics Inc as of Nov 11 - SEC Filing
ReutersNov 18 17:31 ET
ARKK's Holdings Ranked by SA Quant Grades
Seeking AlphaNov 12 14:21 ET
CRISPR, Beam, Other Gene Editing Names up Significantly
Seeking AlphaNov 11 13:15 ET
RBC Capital Maintains Verve Therapeutics(VERV.US) With Buy Rating, Cuts Target Price to $17
Moomoo NewsNov 6 13:32 ET · Ratings

Comments

$Verve Therapeutics (VERV.US)$ hmm

$Verve Therapeutics (VERV.US)$ annnnnnnndd its gone

$Verve Therapeutics (VERV.US)$ premarket looking good

$Verve Therapeutics (VERV.US)$ 👀

1

MARKET-TEST-DUMMY

$Verve Therapeutics (VERV.US)$

Read more